MEG Data Analysis Competitions at Biomag 2022
• Dementia Screening challenge: "your goal is to classify each of the MEG data sets (“test data”, N = 42) into one of three classes: healthy volunteer, mild cognitive impartment (MCI), and dementia"
• Epilepsy challenge: "Two datasets of resting state MEG are provided for analysis. The objective of the challenge is to identify, localize and provide network dynamics of the interictal activity for these two patients."
• Ketamine in depression: "The data include 250 second eyes-closed resting-state data from a randomized, double-blind, placebo-controlled study of ketamine’s mechanisms of action. ... First, you can attempt to classify participants with MDD from healthy control subjects (i.e., a between-subjects factor). Second, you can attempt to classify the scan session (i.e., a within-subjects factor: ketamine versus placebo)."
Deadline: Wednesday 1 June 2022
https://biomag2020.org/awards/data-analysis-competitions/
#MEG #competitions
• Dementia Screening challenge: "your goal is to classify each of the MEG data sets (“test data”, N = 42) into one of three classes: healthy volunteer, mild cognitive impartment (MCI), and dementia"
• Epilepsy challenge: "Two datasets of resting state MEG are provided for analysis. The objective of the challenge is to identify, localize and provide network dynamics of the interictal activity for these two patients."
• Ketamine in depression: "The data include 250 second eyes-closed resting-state data from a randomized, double-blind, placebo-controlled study of ketamine’s mechanisms of action. ... First, you can attempt to classify participants with MDD from healthy control subjects (i.e., a between-subjects factor). Second, you can attempt to classify the scan session (i.e., a within-subjects factor: ketamine versus placebo)."
Deadline: Wednesday 1 June 2022
https://biomag2020.org/awards/data-analysis-competitions/
#MEG #competitions